Inato Raises $14 Million in Series A Funding from Obvious Ventures, Cathay Innovation, Serena and Fly Ventures PARIS, February 4, 2020-- Inato, a platform that helps biopharmaceutical companies increase the pool of available patients engaged in clinical trials, announced it has raised a $14 million Series A round of venture capital financing. The financing was led by Obvious Ventures and Cathay Innovation, with participation from previous investors Serena and Fly Ventures. The Inato platform increases the pool of available patients engaged in clinical trials by unlocking research site potential.
